GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 5 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,016,000 | +7.8% | 4,012,404 | 0.0% | 0.20% | +18.9% |
| Q4 2021 | $4,654,000 | -39.6% | 4,012,404 | 0.0% | 0.17% | -43.9% |
| Q3 2021 | $7,704,000 | -17.9% | 4,012,404 | 0.0% | 0.30% | -14.5% |
| Q2 2021 | $9,389,000 | -13.7% | 4,012,404 | 0.0% | 0.35% | -13.7% |
| Q1 2021 | $10,874,000 | +12.0% | 4,012,404 | 0.0% | 0.41% | +6.8% |
| Q4 2020 | $9,710,000 | +5.7% | 4,012,404 | 0.0% | 0.38% | -23.6% |
| Q3 2020 | $9,188,000 | +97.9% | 4,012,404 | +98.8% | 0.50% | +74.8% |
| Q2 2020 | $4,642,000 | +28.5% | 2,018,398 | -3.9% | 0.29% | -15.1% |
| Q1 2020 | $3,613,000 | -16.9% | 2,100,305 | 0.0% | 0.34% | +2.1% |
| Q4 2019 | $4,348,000 | -28.6% | 2,100,305 | 0.0% | 0.33% | -48.4% |
| Q3 2019 | $6,091,000 | -26.0% | 2,100,305 | 0.0% | 0.64% | -28.8% |
| Q2 2019 | $8,233,000 | – | 2,100,305 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $435,000 | 25.16% |
| COMMODORE CAPITAL LP | 3,079,756 | $3,573,000 | 0.83% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $2,288,000 | 0.26% |
| NEA Management Company, LLC | 10,376,936 | $12,037,000 | 0.24% |
| BVF INC/IL | 4,012,404 | $4,654,000 | 0.17% |
| Avoro Capital Advisors LLC | 5,084,184 | $5,898,000 | 0.10% |
| Boxer Capital, LLC | 1,134,453 | $1,316,000 | 0.05% |
| Ikarian Capital, LLC | 196,821 | $228,000 | 0.03% |
| Empirical Asset Management, LLC | 10,000 | $12,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,652,974 | $3,077,000 | 0.01% |